bpc-157 unapproved new drug fda warning letter The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned The FDA scheduled a hearing
Description
Why are we so meticulous about this
It is grouped with peptide protocols because it shares the injectable research-use format and overlaps with peptide research goals around energy, recovery, and longevity
A medically supervised plan helps determine whether peptide therapy is appropriate, which peptide fits the goal, and how to monitor results safely
Tendons heal notoriously slowly because they have limited blood supply and relatively few growth factor receptors
